FDA approval allows market entry for devices from Dexcom and Intuitive Surgical.
2 reports, 2 independent
Updated Jul 28
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA approval allows market entry for devices from Dexcom and Intuitive Surgical.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
Nothing else this week.
-
Intuitive Surgical
American corporation
Nothing else this week.
Related events
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- Policymakers are considering ways to influence the drug market, including potential changes to patent rights and the FDA approval process.
- Vivos is advancing its product line by securing patents via USPTO filings and gaining unprecedented 510K clearances for an alternative to CPAP technology.
- ADC Therapeutics received accelerated approval for its drug from the FDA.
- Generic medicine services are seeking approval for launch from the FDA.
Coverage
Newest first; wire copies grouped- fool.comHere's Exactly Why Wall Street Thinks Intuitive Surgical Stock Could Soar 102% Over the Next 12 Months | The Motley Fool
- financialcontent.com